vam6 Antibody

Shipped with Ice Packs
In Stock

Description

Definition and Characteristics of Vam6 Antibody

The Vam6 antibody targets the Vam6/Vps39 protein, a conserved component of the HOPS complex (Homotypic fusion and Protein Sorting) and vCLAMP (vacuole and mitochondria patch) structures. These complexes mediate organelle fusion, nutrient transport, and stress responses in eukaryotic cells .

Key attributes of Vam6 antibodies include:

  • Host species: Rabbit (polyclonal) .

  • Reactivity: Broad cross-species recognition, including Saccharomyces cerevisiae, Candida albicans, Cryptococcus neoformans, and mammalian systems .

  • Immunogen: Typically derived from a synthetic peptide or recombinant protein fragment (e.g., residues 710–760 in human VPS39) .

  • Applications: Western blot (WB), ELISA, immunofluorescence, and co-immunoprecipitation (Co-IP) .

Role in Fungal Pathogenesis

Vam6 is critical for virulence in fungal pathogens:

  • In Candida albicans, Vam6 deficiency leads to mitochondrial swelling, reduced antioxidant enzyme activity, and impaired hyphal development under oxidative stress .

  • Cryptococcus neoformans mutants lacking Vam6 exhibit defective polyphosphate metabolism, mitochondrial dysfunction, and attenuated virulence .

Mitochondrial-Vacuolar Interactions

Vam6 facilitates vCLAMP formation, which regulates:

  • Phospholipid trafficking between mitochondria and vacuoles .

  • Polyphosphate (polyP) synthesis and oxidative stress responses .

Immune Cell Modulation

In tumor immunology, Vam6 modulates iNKT cell function:

  • Increased Vam6 expression suppresses mTORC1 activation and IFN-γ production via Rab7a-Vam6-AMPK complex formation .

  • Targeting Vam6 enhances anti-tumor efficacy by restoring iNKT cell activity .

Therapeutic Implications

  • In cancer, reducing Vam6 expression in iNKT cells enhances mTORC1 signaling and IFN-γ production, improving anti-tumor responses .

  • Fungal Vam6 is a potential drug target due to its role in oxidative stress resistance and virulence .

Product Specs

Buffer
Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, pH 7.4
Form
Liquid
Lead Time
Made-to-order (14-16 weeks)
Synonyms
vam6 antibody; vps39 antibody; SPAC23H4.14 antibody; Vacuolar morphogenesis protein 6 antibody; Vacuolar protein sorting-associated protein 39 antibody
Target Names
vam6
Uniprot No.

Target Background

Function
Vam6 antibody is essential for vacuolar assembly. It functions as a component of the HOPS complex, playing a crucial role during the docking stage of vacuole fusion. The HOPS complex is required for the assembly of vacuolar SNARE complexes. Notably, Vam6 antibody remains bound to SNARE complexes even after vacuole fusion has occurred.
Database Links
Protein Families
VAM6/VPS39 family
Subcellular Location
Vacuole membrane; Peripheral membrane protein.

Q&A

What is Vam6/Vps39 and why is it important in cellular biology research?

Vam6/Vps39 is a multifunctional protein that serves critical roles in various cellular processes. It functions as a component of both the homotypic fusion and vacuole protein sorting (HOPS) complex and vacuole and mitochondria patch (vCLAMP) membrane contact sites. Research has demonstrated that Vam6 is essential for:

  • Vacuolar morphology maintenance and function

  • Mitochondrial health and resistance to oxidative stress

  • Endomembrane trafficking

  • Polyphosphate (polyP) metabolism

  • TORC1 pathway regulation in response to amino acids

In fungal pathogens like Candida albicans and Cryptococcus neoformans, Vam6 plays crucial roles in virulence and stress responses . In mammalian systems, Vam6 has been implicated in immune cell function through modulation of AMPK-mTORC1 signaling pathways .

What are the common applications for Vam6/Vps39 antibodies in research?

Vam6/Vps39 antibodies have been validated for multiple experimental applications:

ApplicationTypical Working DilutionCommon Sample Types
Western Blot0.5-1 μg/mLCell/tissue lysates
Immunohistochemistry5-20 μg/mLParaffin-embedded tissues
Immunofluorescence5-20 μg/mLFixed cells, tissue sections
ELISAVaries by antibodyPurified protein, cell lysates
Co-immunoprecipitationVaries by experimentCell lysates

When selecting antibodies, researchers should consider specificity across isoforms, as at least four isoforms of Vps39 are known to exist in mammals . Validation across multiple applications is recommended to ensure reliability in your specific experimental system.

How can I effectively validate Vam6 subcellular localization in different organelles?

Vam6 has been reported to localize to multiple cellular compartments, primarily vacuolar membranes and mitochondria-vacuole contact sites (vCLAMPs). A comprehensive validation approach should include:

  • Co-localization studies: Use established organelle markers alongside Vam6 antibodies:

    • Vacuolar membrane: FM4-64 or LAMP2

    • Mitochondria: MitoTracker Red or Tom20

    • Late endosomes: Rab7a

  • Multiple imaging techniques:

    • Fluorescence microscopy for general co-localization

    • Confocal microscopy for improved resolution

    • Immunoelectron microscopy (IEM) for precise localization at contact sites

  • Functional verification: In C. albicans, researchers labeled mitochondria with Csp37-GFP (outer mitochondrial membrane) alongside vacuole markers to confirm Vam6's role in vCLAMP formation .

Critically, Vam6 localization can be influenced by nutritional status and stress conditions. For example, in S. pombe, Vam6-Gtr1 interaction was only detectable in cells grown with amino acids, not during nitrogen starvation, despite co-localization under both conditions .

What considerations should be made when using Vam6 antibodies across different species?

Vam6/Vps39 shows varying degrees of conservation across species, affecting antibody selection and experimental design:

SpeciesKey ConsiderationsValidated Applications
HumanMultiple isoforms exist; antibody may detect all fourWB, IF, IHC-P, ELISA
MouseOften used in knockout/heterozygous modelsWB, IF, IHC-P
RatLimited validation in some antibody productsWB, sometimes IF
S. cerevisiaeCalled Vam6; differs from mammalian homologsWB, ELISA
C. albicansHomolog of S. cerevisiae Vps39Genetic studies primarily
C. neoformansCalled Vam6/Vps39/TRAP1-domain proteinGenetic studies primarily

When working with fungal systems, researchers have often relied on epitope tagging (GFP, mCherry) rather than antibodies against the native protein . For cross-species studies, western blotting with appropriate controls should be performed to confirm antibody specificity.

How do I design experiments to investigate Vam6's dual roles in HOPS complex and vCLAMP formation?

Distinguishing between Vam6's functions in different protein complexes requires careful experimental design:

  • Domain-specific approaches:

    • Generate truncation mutants targeting specific domains (ΔCT, ΔCLH, ΔCNH) to selectively impair different functions

    • Use lentiviral vectors expressing mCherry-tagged constructs for functional rescue experiments

  • Co-immunoprecipitation strategy:

    • For HOPS complex: Pull down with antibodies against other HOPS components

    • For vCLAMP: Co-IP with mitochondrial proteins like VDAC1 and lysosomal proteins like Rab7a

  • Phenotypic analysis:

    • HOPS disruption: Monitor vacuolar morphology using vacuole-specific dyes (MDY64, c-DCFDA)

    • vCLAMP disruption: Assess mitochondrial function, ROS levels, and polyP metabolism

In C. neoformans, researchers investigating these dual roles used a comprehensive approach combining morphological studies, organelle-specific staining, and metabolic phenotyping to distinguish HOPS vs. vCLAMP functions of Vam6 .

What are the most effective approaches for studying Vam6's role in oxidative stress response?

Investigating Vam6's function in oxidative stress response requires multi-parameter analysis:

  • ROS measurement techniques:

    • Flow cytometry with ROS-sensitive dyes (DCFDA)

    • Plate-based fluorometric assays for high-throughput screening

    • Mitochondrial superoxide indicators for organelle-specific ROS

  • Mitochondrial function assessment:

    • mtDNA damage quantification

    • Electron transport chain complex activity assays

    • Mitochondrial membrane potential measurement

    • Transmission electron microscopy for morphological changes

  • Antioxidant enzyme profiling:

    • Measure SOD1 activity in wild-type vs. vam6 mutants

    • Quantify glutathione levels and recycling

In C. albicans, researchers found that vam6Δ/Δ mutants showed increased sensitivity to H₂O₂, with reduced antioxidant enzyme activity and elevated ROS levels. Similarly, in C. neoformans, deletion of Vam6 resulted in increased ROS accumulation when cells were treated with hemin .

What are the optimal conditions for using Vam6 antibodies in co-immunoprecipitation experiments?

Successful co-immunoprecipitation of Vam6 and its interaction partners requires careful optimization:

  • Lysis buffer selection:

    • NP-40 buffer has been successfully used for Vam6 co-IP

    • Include protease inhibitor cocktail to prevent degradation

    • Consider phosphatase inhibitors when studying signaling interactions

  • Antibody-bead preparation:

    • Pre-incubate antibodies with Dynabeads protein G at 4°C for at least 30 minutes

    • Use 1-5 μg of antibody per sample

    • Include appropriate isotype controls (e.g., rabbit IgG)

  • Incubation conditions:

    • Overnight incubation at 4°C improves yield

    • Gentle rotation to maintain bead suspension without damaging complexes

  • Known technical challenges:

    • Some Vam6 interactions (e.g., with Gtr1) are condition-dependent and only occur in the presence of amino acids

    • Membrane-associated complexes may require additional optimization of detergent conditions

For protein complexes at membrane contact sites, such as vCLAMPs, crosslinking prior to lysis may help preserve transient interactions between organelles.

How can discrepancies in Vam6 molecular weight observations be addressed in western blotting?

Researchers have reported variations in the observed molecular weight of Vam6/Vps39:

SourceCalculated MWObserved MWPossible Explanation
Human VPS39101.8 kDa68 kDaPost-translational modifications, isoforms
Yeast Vam6Varies by speciesMultiple bandsDegradation products, splice variants

To address these discrepancies:

  • Sample preparation optimization:

    • Include fresh protease inhibitors

    • Avoid repeated freeze-thaw cycles

    • Consider gentler lysis methods for membrane proteins

  • Control experiments:

    • Include positive controls from validated sources

    • Use blocking peptides to confirm specificity

    • Compare wild-type and knockout/knockdown samples

  • Antibody validation:

    • Test multiple antibodies targeting different epitopes

    • Verify with tagged constructs (GFP/mCherry-Vam6) using tag-specific antibodies

If multiple bands are observed, phosphatase treatment can help determine if post-translational modifications contribute to the molecular weight variation.

How can Vam6 research inform therapeutic strategies for fungal infections?

Recent studies highlight Vam6's potential as a therapeutic target for fungal infections:

  • Virulence connection:

    • In C. albicans, vam6Δ/Δ mutants showed attenuated host invasion and virulence

    • C. neoformans lacking Vam6 demonstrated impaired iron acquisition and reduced virulence

  • Potential intervention strategies:

    • Target vCLAMP formation to disrupt fungal stress responses

    • Inhibit Vam6-dependent iron acquisition pathways

    • Disrupt vacuolar function essential for fungal survival under host conditions

  • Therapeutic considerations:

    • Structural differences between fungal and mammalian Vam6 could enable selective targeting

    • Combination approaches targeting both Vam6 and other stress response pathways may increase efficacy

The World Health Organization recently ranked C. neoformans in the critical priority group for public health importance, highlighting the need for novel antifungal strategies .

What are the emerging techniques for studying Vam6 dynamics in living cells?

Advanced methodologies are expanding our understanding of Vam6 biology:

  • Live-cell imaging approaches:

    • Photo-switchable fluorescent proteins to track Vam6 movement between compartments

    • FRET-based sensors to detect protein-protein interactions in real-time

    • Lattice light-sheet microscopy for improved spatiotemporal resolution

  • Proximity labeling techniques:

    • BioID or APEX2 fusions to identify proteins in close proximity to Vam6

    • Helps identify transient interaction partners at membrane contact sites

  • CRISPR-based technologies:

    • CRISPR/Cas9 for generating precise knockout models like Vam6+/- mice

    • CRISPR activation/inhibition for modulating Vam6 expression without genetic deletion

  • Functional sensors:

    • Heme sensors using eGFP/mKATE2 ratiometric measurement to study Vam6's role in heme trafficking

    • ROS indicators to monitor oxidative stress in real-time

These advanced techniques provide unprecedented insights into the dynamic roles of Vam6 in various cellular processes and disease states.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.